40 related articles for article (PubMed ID: 16765382)
21. Emerging preclinical pharmacological targets for Parkinson's disease.
More SV; Choi DK
Oncotarget; 2016 May; 7(20):29835-63. PubMed ID: 26988916
[TBL] [Abstract][Full Text] [Related]
22. Regulation of copper transport crossing brain barrier systems by Cu-ATPases: effect of manganese exposure.
Fu X; Zhang Y; Jiang W; Monnot AD; Bates CA; Zheng W
Toxicol Sci; 2014 Jun; 139(2):432-51. PubMed ID: 24614235
[TBL] [Abstract][Full Text] [Related]
23. Substitution p.A350V in Na⁺/Mg²⁺ exchanger SLC41A1, potentially associated with Parkinson's disease, is a gain-of-function mutation.
Kolisek M; Sponder G; Mastrototaro L; Smorodchenko A; Launay P; Vormann J; Schweigel-Röntgen M
PLoS One; 2013; 8(8):e71096. PubMed ID: 23976986
[TBL] [Abstract][Full Text] [Related]
24. Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.
Garcia-Garcia A; Zavala-Flores L; Rodriguez-Rocha H; Franco R
Antioxid Redox Signal; 2012 Dec; 17(12):1764-84. PubMed ID: 22369136
[TBL] [Abstract][Full Text] [Related]
25. Nutrition and the risk for Parkinson's disease: review of the literature.
Gaenslen A; Gasser T; Berg D
J Neural Transm (Vienna); 2008 May; 115(5):703-13. PubMed ID: 18188495
[TBL] [Abstract][Full Text] [Related]
26. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: An approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier.
Nischwitz V; Berthele A; Michalke B
Anal Chim Acta; 2008 Oct; 627(2):258-69. PubMed ID: 18809082
[TBL] [Abstract][Full Text] [Related]
27. Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease.
Forte G; Bocca B; Senofonte O; Petrucci F; Brusa L; Stanzione P; Zannino S; Violante N; Alimonti A; Sancesario G
J Neural Transm (Vienna); 2004 Aug; 111(8):1031-40. PubMed ID: 15254791
[TBL] [Abstract][Full Text] [Related]
28. Elemental profile of cerebrospinal fluid in patients with Parkinson's disease.
Alimonti A; Bocca B; Pino A; Ruggieri F; Forte G; Sancesario G
J Trace Elem Med Biol; 2007; 21(4):234-41. PubMed ID: 17980814
[TBL] [Abstract][Full Text] [Related]
29. Calcium, copper, iron, magnesium, silicon and zinc content of hair in Parkinson's disease.
Forte G; Alimonti A; Violante N; Di Gregorio M; Senofonte O; Petrucci F; Sancesario G; Bocca B
J Trace Elem Med Biol; 2005; 19(2-3):195-201. PubMed ID: 16325536
[TBL] [Abstract][Full Text] [Related]
30. Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair. Reference values.
Goullé JP; Mahieu L; Castermant J; Neveu N; Bonneau L; Lainé G; Bouige D; Lacroix C
Forensic Sci Int; 2005 Oct; 153(1):39-44. PubMed ID: 15979835
[TBL] [Abstract][Full Text] [Related]
31. Review on metal speciation analysis in cerebrospinal fluid-current methods and results: a review.
Michalke B; Nischwitz V
Anal Chim Acta; 2010 Dec; 682(1-2):23-36. PubMed ID: 21056712
[TBL] [Abstract][Full Text] [Related]
32. Metal changes in CSF and peripheral compartments of parkinsonian patients.
Bocca B; Alimonti A; Senofonte O; Pino A; Violante N; Petrucci F; Sancesario G; Forte G
J Neurol Sci; 2006 Oct; 248(1-2):23-30. PubMed ID: 16765382
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
